logo

For the Inventor, By the Inventor

Mainz, Germany

Harald Schmitt

This inventor holds 9 USPTO granted patents and 8 published patent applications. Top assignees: Intervet Inc., 4Sc Ag. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harald Schmitt. Retrieved from https://idiyas.com/inventor/harald-schmitt-2t03h7jb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 44.4

Average Co-Inventor Count = 1.9

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:

goldMedal5 out of 272 
 
Intervet Inc.
 patents
silverMedal4 out of 52 
 
4Sc Ag
 patents

Years Active: 2008-2026

Loading Chart...
9 patents (USPTO):Explore Patents
1. 12655090 - Cyclopropylamide compounds against parasites in fish (2026-06-16),
2. 12479835 - Process for preparing 1-([3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide (2025-11-25),
3. 12077514 - Method for racemisation of (5R)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H¬isoxazol-3-yl]-2-methyl-benzoic acid (2024-09-03),
4. 11548859 - Method for producing (5,S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4Hisoxazol-3-yl]-2-methyl-benzoic acid (2023-01-10),
5. 11530187 - Method for producing (5S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-benzoic acid (2022-12-20),
6. 8106048 - Heterocyclic NF-κB inhibitors (2012-01-31),
7. 7812041 - Heterocyclic NF-κB inhibitors (2010-10-12),
8. 7601745 - Heterocyclic NF-kB inhibitors (2009-10-13),
9. 7317030 - Compounds as inhibitors of cell proliferation and viral infections (2008-01-08),

Title: The Innovative Contributions of Harald Schmitt

Introduction

Harald Schmitt is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of chemistry, particularly in the development of methods for synthesizing complex compounds. With a total of seven patents to his name, Schmitt's work has had a considerable impact on various applications in the pharmaceutical industry.

Latest Patents

Among his latest patents, Schmitt has developed a method for the racemization of (5R)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-benzoic acid. This invention relates to a novel approach for racemizing this specific compound, which is crucial for various chemical processes. Additionally, he has patented a method for producing (5S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-benzoic acid. This method can be utilized in the synthesis of related compounds, showcasing Schmitt's innovative capabilities in chemical synthesis.

Career Highlights

Throughout his career, Schmitt has worked with several prominent companies, including 4SC AG and Intervet Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development projects.

Collaborations

Schmitt has collaborated with notable colleagues such as Johann Leban and Kristina Wolf. These partnerships have fostered a collaborative environment that has led to the advancement of innovative solutions in their respective fields.

Conclusion

Harald Schmitt's contributions to the field of chemistry through his patents and collaborations highlight his role as a significant inventor. His innovative methods for synthesizing complex compounds continue to influence the pharmaceutical industry and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…